Benzinga | Nov 10, 2021 06:44PM EST

VistaGen Therapeutics Q2 EPS $(0.07) Down From $(0.05) YoY, Sales $358.00K Up From $334.00K YoY

VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly losses of $(0.07) per share. This is a 40 percent decrease over losses of $(0.05) per share from the same period last year. The company reported $358.00 thousand in sales this quarter. This is a 7.19 percent increase over sales of $334.00 thousand the same period last year.